Raúl M. Luque is a professor of cell biology at the University of Córdoba (UCO) and principal investigator of the OncObesity and Metabolism group at the Maimónides Institute of Biomedical Research of Córdoba (IMIBIC). He started his scientific career with a competitive FPU grant (Spanish Ministry of Science) and continued his postdoctoral training with a contract with Junta de Andalucía (JdA) and then as a researcher assistant professor at the University of Illinois at Chicago (USA; 2003–07). In 2007, he rejoined UCO as a Ramón y Cajal Researcher, establishing his own line of research as the PI of the group. Since then, he has obtained research funds (as PI) for several public (MICINN, FIS-ISCIII, DTSISCIII, JdA, CIBERobn, Merck-Serono, Caixa-Impulse, FIPSE, Fundación Inocente-Inocente, etc.) and private (IPSEN, Novartis, Lilly, etc.) projects and participates in national and international programs, demonstrating his leadership capacity. He has published more than 220 articles in prestigious and high-impact international journals (e.g. Molecular Cancer, Clinical Cancer Research, Brain, EBioMedicine, FASEB J, etc.), more than 70% in Q1 and 27% in D1: Areas of Oncology, Endocrinology and Metabolism, a large percentage as first (32: 15%) or last author (100: 45%), with 122 of these in the last 5 years (2018-present), and 45 book chapters. He has contributed to more than 600 communications to congresses, many of them by invitation (more than 50 invitations in the last 10 years).